InvestorsHub Logo

Gpheart2016

11/10/21 12:17 PM

#666 RE: Man6677 #665

Agree. Investors appear to be favoring BNTX over Moderna after MRNA’s earnings miss. I’m bullish on both but added BNTX shares today. If earnings estimates are accurate for the next four quarters, this stock is cheap at $240